Sothema

As of August 30, 2026, Sothema trades at 360.00 MAD on the Casablanca Stock Exchange. Sothema operates in the Santé sector.

Price
360.00 MAD−2.2%
Market cap
13.8 bn MAD
Business

What does Sothema do?

Société de Thérapeutique Marocaine (Sothema) is a Moroccan pharmaceutical laboratory founded in 1976, specializing in the manufacturing and marketing of medicines. The company produces generics and licensed products, manufactures for international laboratories and is developing a biotechnology business.

Source: company official website

Performance

Sothema performance

Stock performance over the main periods. Price as of August 30, 2026. Click a period to update the chart.

from Dec 30, 2025 to Aug 27, 2026
Price trend

As of August 30, 2026, Sothema trades at 360.00 MAD, up 1.3% year to date.

Valuation ratios

Sothema ratios

Valuation and profitability ratios, as of August 27, 2026.

P/E
36.29×
Price / Book (P/B)
5.34×
Dividend yield
1.5%
ROE
14.7%

Ratios computed from the share price and the latest published financial statements.

Dividends

Sothema dividend

Sothema paid a dividend of 6.60 MAD per share in 2026 for the 2025 financial year, with an ex-dividend date of July 1, 2026 on the Casablanca Stock Exchange. Yuna documents 10 dividend financial years for Sothema, from the oldest (2016) to the most recent (2025).

Financial yearDividend per shareEx-dividend date
2025
paid in 2026
6.60 MADJuly 1, 2026
2024
paid in 2025
28.00 MADJune 20, 2025
2023
paid in 2024
17.00 MADJune 21, 2024
Show 7 earlier financial years
2022
paid in 2023
25.00 MADJuly 3, 2023
2021
paid in 2022
25.00 MADJune 24, 2022
2020
paid in 2021
21.00 MADJuly 15, 2021
2019
paid in 2020
67.00 MADJuly 15, 2020
2018
paid in 2019
67.00 MADJune 25, 2019
2017
paid in 2018
56.00 MADJune 26, 2018
2016
paid in 2017
56.00 MADJune 29, 2017

Dividend history updated on August 30, 2026.

Fund ownership

The funds that own Sothema

Owning funds
87
Assets held
557.6 M MAD
Share of market cap
4.0%

87 Moroccan funds own Sothema, for 557.6 M MAD of combined assets, 4.0% of market cap. As of the latest published inventory (December 31, 2025).

The list of owning funds

The breakdown of the 87 owning funds and the stock's weight in each portfolio is for subscribers.

••••
••
••••
••
••••
••
For subscribers
See plans
Financial analysis

Detailed financial analysis of Sothema

Margins, EV/EBITDA, leverage, sector KPIs and earnings history, for subscribers.

••
••••
••
••••
••
••••
••
••••
••
••••
••
••••
For subscribers
See plans
Keep exploring

Keep exploring the Moroccan market

Compare Sothema with the other Santé stocks, in the full market directory. Casablanca Stock Exchange directory
Each fund that owns Sothema has its own public page. Moroccan fund directory
FAQ

Frequently asked questions about Sothema

What does Sothema do?
Société de Thérapeutique Marocaine (Sothema) is a Moroccan pharmaceutical laboratory founded in 1976, specializing in the manufacturing and marketing of medicines. The company produces generics and licensed products, manufactures for international laboratories and is developing a biotechnology business.
What is the share price of Sothema?
As of August 30, 2026, Sothema trades at 360.00 MAD on the Casablanca Stock Exchange.
In which sector does Sothema operate?
Sothema is a Santé company listed on the Casablanca Stock Exchange.
What is the Sothema dividend?
Sothema paid a dividend of 6.60 MAD per share in 2026 for the 2025 financial year, with an ex-dividend date of July 1, 2026 on the Casablanca Stock Exchange.
When does Sothema go ex-dividend?
The latest known ex-dividend date for Sothema is July 1, 2026, for the 2025 financial year.
Which Moroccan funds own Sothema?
87 Moroccan funds own Sothema, for 557.6 M MAD of combined assets, as of the latest published inventory.
Widget

Embed this stock on your website

Display this stock's price and performance card on your website, updated with every published session.

Widget preview
Get the embed code

Data updated automatically · last update: August 30, 2026

YunaYuna

Analyze Sothema and the whole Casablanca market

Price, ratios, earnings, fund ownership and comparator, with a Yuna subscription.